← Leaderboards
Haijing Huang
Rand Corporation
$1,625,090
Attributed
$3,250,180
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $724.4K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,250,180 · 1
By mechanism
R01$3,250,180 · 1
Top collaborators
- Sebastian Linnemayr5 shared
Most similar at Rand Corporation
Same institution · by research overlap
- Sebastian Linnemayr$10,125,411
- Dana P Goldman$26,931,376
- James Patrick Smith$45,667,935
- Michael D Hurd$38,668,869
- Arie Kapteyn$101,412,267
Others in their field
Other Emerging Leaders on “Eligibility Determination”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$76,896,871
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- James Dale Berry · Brigham And Women'S Hospital$15,344,018
- Jennifer Marie Suga · Kaiser Foundation Research Institute$14,365,962
- Andrew S Huhn · Johns Hopkins University$12,205,195
Research focus
Eligibility DeterminationEffectivenessDropoutEffectiveness TestingBehaviorAgedAmericanBehavior ChangeAdherenceEffectiveness EvaluationClientCognitive ControlBehavioralComparativeBehavioral EconomicsControl GroupsCostCost EffectivenessCost Effectiveness AnalysisCountryCovid-19DesignDiscountingEmpowerment
Grant awards (5)
Goals for Adherence with Low-cost Incentives (GOALS)$574,419
R01 · FY2025 · HD
Goals for Adherence with Low-cost Incentives (GOALS)$616,721
R01 · FY2024 · HD
Goals for Adherence with Low-cost Incentives (GOALS)$668,122
R01 · FY2023 · HD
Goals for Adherence with Low-cost Incentives (GOALS)$666,473
R01 · FY2022 · HD
Goals for Adherence with Low-cost Incentives (GOALS)$724,445
R01 · FY2021 · HD